Editorial: Allostatic Load and Inflammatory Bowel Disease
- PMID: 39601634
- DOI: 10.1111/apt.18325
Editorial: Allostatic Load and Inflammatory Bowel Disease
References
-
- J. Zhao, E. Xue, S. Zhou, et al., “Allostatic Load Increases the Incidence and Risk of Adverse Prognosis in Inflammatory Bowel Disease,” Alimentary Pharmacology & Therapeutics 60 (2024): 1062–1074, https://doi.org/10.1111/apt.18217.
-
- F. Osei, A. Block, and P.‐M. Wippert, “Association of Primary Allostatic Load Mediators and Metabolic Syndrome (MetS): A Systematic Review,” Frontiers in Endocrinology 13 (2022): 1–16, https://doi.org/10.3389/fendo.2022.946740.
-
- T. E. Seeman, B. S. McEwen, J. W. Rowe, and B. H. Singer, “Allostatic Load as a Marker of Cumulative Biological Risk: MacArthur Studies of Successful Aging,” Proceedings of the National Academy of Sciences of the United States of America 98, no. 8 (2001): 4770–4775, https://doi.org/10.1073/pnas.081072698.
Publication types
LinkOut - more resources
Full Text Sources